The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letter to the EditorFull Access

Dr. Allison Replies

To the Editor: The purpose of our article was to present the most comprehensive information available at that time regarding the weight-gain-inducing potential of various antipsychotic agents. Of course, the information available at any one point in time will never be complete. Therefore, we are pleased to see the letter from Drs. Hellewell and Haddad and would like to present some additional information regarding quetiapine of which we have now become aware. According to the Canadian product monograph (1), “In clinical trials mean weight gain after 4–8 weeks of treatment was approximately 2.1 kg, after 18–26 weeks, 3.5 kg, and at 1 year, 5.6 kg.” These data then are consistent with those cited by Drs. Hellewell and Haddad on short-term weight gain but show markedly greater weight gain at 1 year. We hope this information is useful to readers.

Reference

1. Zeneca Pharmaceuticals: Seroquel (quetiapine tablets) Product Monograph. Wilmington, Del, Zeneca, Dec 2, 1997Google Scholar